Medtopas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 663,363 | 1,337,244 | 2,028,517 | 1,544,790 | 1,599,034 | 2,514,182 | 2,150,153 | 2,153,749 |
| Profit before tax | 21,143 | 32,453 | 375,135 | 59,857 | 28,085 | 37,400 | 13,964 | 81,601 |
| Net profit | 17,972 | 27,362 | 318,865 | 50,878 | 23,872 | 31,790 | 11,869 | 68,281 |
| Equity | 20,868 | 48,230 | 367,095 | 415,025 | 377,643 | 350,541 | 362,410 | 230,695 |
| Liabilities | 202,594 | 472,212 | 364,017 | 746,332 | 532,099 | 480,542 | 665,161 | 415,168 |
| Non-current assets | 8,579 | 181,414 | 220,694 | 303,559 | 375,302 | 305,669 | 172,725 | 18,590 |
| Current assets | 214,883 | 339,028 | 510,418 | 853,897 | 567,030 | 533,677 | 838,638 | 617,112 |
| Total assets | 223,462 | 520,442 | 731,112 | 1,157,456 | 942,332 | 839,346 | 1,011,363 | 635,702 |
|
Taxes paid
|
||||||||
| Social insurance contributions | - | - | - | - | - | 125,474 | 136,347 | 125,384 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +61608.2% | +101.6% | +51.7% | -23.8% | +3.5% | +57.2% | -14.5% | +0.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 8.0% | 5.3% | 43.6% | 4.4% | 2.5% | 3.8% | 1.2% | 10.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 86.1% | 56.7% | 86.9% | 12.3% | 6.3% | 9.1% | 3.3% | 29.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.7% | 2.0% | 15.7% | 3.3% | 1.5% | 1.3% | 0.6% | 3.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.2% | 2.4% | 18.5% | 3.9% | 1.8% | 1.5% | 0.6% | 3.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 9.7 | 9.8 | 1.0 | 1.8 | 1.4 | 1.4 | 1.8 | 1.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 45,749 | 63,932 | 105,835 | 72,696 | 64,175 | 97,323 | 89,280 | 103,795 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medtopas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-03 | 2026-05-05 | 1.71 |
| 2026-04-23 | 2026-04-29 | 1.71 |
| 2026-01-21 | 2026-02-17 | 12.26 |
| 2025-10-16 | 2025-10-19 | 9435.40 |
| 2024-10-24 | 2024-10-29 | 1.26 |
| 2024-07-17 | 2024-07-17 | 1801.41 |
| 2022-11-21 | 2022-12-08 | 966.62 |
| 2022-11-17 | 2022-11-18 | 966.62 |
| 2022-11-03 | 2022-11-13 | 2006.62 |
| 2022-10-28 | 2022-11-02 | 2006.62 |
| 2022-10-18 | 2022-10-27 | 2005.68 |
| 2022-10-03 | 2022-10-10 | 2995.68 |
| 2022-09-16 | 2022-10-02 | 2995.68 |
| 2022-09-01 | 2022-09-13 | 3985.68 |
| 2022-08-23 | 2022-08-31 | 3985.68 |
| 2022-08-01 | 2022-08-09 | 4977.73 |
| 2022-07-18 | 2022-07-31 | 4977.73 |
| 2022-06-16 | 2022-07-10 | 5913.13 |
| 2022-05-17 | 2022-06-07 | 6903.13 |
| 2022-05-11 | 2022-05-12 | 6901.79 |
| 2022-04-19 | 2022-05-10 | 7891.79 |
| 2022-03-16 | 2022-04-07 | 8887.51 |
| 2022-03-08 | 2022-03-15 | 2749.51 |
| 2022-02-24 | 2022-03-07 | 9887.51 |
| 2022-02-17 | 2022-02-23 | 9890.51 |
| 2022-02-09 | 2022-02-16 | 3577.35 |
| 2022-01-28 | 2022-02-08 | 10880.51 |
| 2022-01-18 | 2022-01-27 | 10878.38 |
| 2022-01-13 | 2022-01-17 | 3900.79 |
| 2021-12-22 | 2022-01-12 | 11868.38 |
| 2021-12-20 | 2021-12-21 | 12242.20 |
| 2021-12-16 | 2021-12-19 | 12243.93 |
| 2021-12-01 | 2021-12-15 | 13233.94 |
| 2021-11-24 | 2021-11-30 | 13233.94 |
| 2021-11-16 | 2021-11-23 | 12858.39 |
| 2021-11-15 | 2021-11-15 | 7122.23 |
| 2021-11-03 | 2021-11-14 | 13848.39 |
| 2021-10-18 | 2021-11-02 | 13848.39 |
| 2021-10-13 | 2021-10-17 | 7895.20 |
| 2021-10-01 | 2021-10-12 | 14838.39 |
| 2021-09-16 | 2021-09-30 | 14838.39 |
Medtopas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-22 | 2025-07-22 | 8816.28 |
| 2025-07-20 | 2025-07-21 | 8809.32 |
| 2025-07-19 | 2025-07-19 | 8807.0 |
| 2025-07-18 | 2025-07-18 | 8897.23 |
| 2025-07-17 | 2025-07-17 | 19727.46 |
| 2025-07-16 | 2025-07-16 | 19423.65 |
| 2025-06-20 | 2025-06-26 | 2742.77 |
| 2025-06-18 | 2025-06-19 | 2741.31 |
| 2025-06-17 | 2025-06-17 | 2725.37 |
| 2025-05-29 | 2025-05-29 | 46244.74 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medtopas, UAB (code 303313081) is a Private Limited Liability Company operating in construction of utility projects for fluids. In 2025, the company generated revenue of €2.15M, essentially unchanged year on year (+0.2%), while revenue remained below the 2023 level of €2.51M. Net profit increased to €68.3K in 2025 from €11.9K in 2024 and €31.8K in 2023, lifting the profit margin to 3.2% after 0.6% in 2024 and 1.3% in 2023. This indicates a stronger profitability profile despite flat sales. The balance sheet in 2025 shows total assets of €635.7K, equity of €230.7K and liabilities of €415.2K. Compared with 2024, assets and liabilities decreased, and equity also declined. Key ratios for 2025 point to solid operating efficiency, with ROE at 29.6%, ROA at 10.7%, debt-to-equity at 1.80 and asset turnover at 3.39x. Revenue per employee was €107.7K, while profit per employee was €3.4K, suggesting moderate productivity.